EXIT-CVD Consortium Launches Heart Health Research Project
A new international initiative aims to improve cardiovascular care through 22 clinical studies involving 14,000 patients.
Updated on Oct. 15, 2026 in Heart Disease
Live Poll
Should medical research projects prioritize advanced technology over ensuring equal access for all patient populations?
The EXIT-CVD research consortium has launched a five-year cardiovascular health project to address heart disease. The initiative, funded by EUR 27.6 million, will conduct 22 clinical studies involving over 14,000 patients across 17 countries.
Why it matters
With over 60 million people in the European Union living with cardiovascular disease, the project seeks to prevent patient deterioration via early, personalized interventions. It also aims to bridge critical socioeconomic, gender, and digital access gaps in current cardiac care.
The EXIT-CVD project operates with a total budget of EUR 27.6 million involving 42 partners across 17 countries. Researchers will utilize innovations ranging from contactless monitoring to spectral CT imaging to study 14,000-plus patients.
The players
University Medical Center Groningen
This is a major academic medical center located in the Netherlands that serves as a research leader for the consortium.
Philips
Headquartered in the Netherlands, this multinational technology corporation focuses on health technology and medical imaging solutions.
European Union Innovative Health Initiative
This public-private partnership funds health research across Europe to accelerate the development of innovative healthcare solutions.
The details
Co-led by the University Medical Center Groningen and Philips, the consortium will focus on early detection, disease reversal, and halting the progression of advanced heart conditions. Data will be processed through a FAIR-compliant platform aligned with the European Health Data Space.
Timeline
October 2026: Patient enrollment begins for the first clinical studies.
Five-year duration: The total planned lifespan of the EXIT-CVD research project.
The Big Picture
The EXIT-CVD project aligns its clinical research and data protocols with the European Health Data Space. This integration marks a shift toward standardized, cross-border digital health research within the European Union.
The project aims to improve long-term outcomes for heart patients by moving toward early detection and personalized intervention strategies. Patients may eventually benefit from more precise diagnostic tools like spectral CT imaging developed during the study.
The takeaway
This initiative represents a significant commitment to reducing the burden of heart disease through large-scale, international collaboration. Patients and healthcare providers should anticipate that these research milestones will gradually refine how cardiovascular risk is identified and treated.
Further reading
Learn more about the latest diagnostic and treatment breakthroughs in Heart Disease.
Live Poll
Should medical research projects prioritize advanced technology over ensuring equal access for all patient populations?
